Skip to main content

Psoriasis

Psoriasis

Featured

Derm Q&A
Psoriasis is associated with many comorbid conditions. In an interview with The Dermatologist, Ronald Prussick, MD, discusses the latest research on these comorbidities, evidence on lifestyle and treatment options that could potentially prevent or manage both psoriasis and comorbid conditions, and the importance of screening and aggressively treating psoriatic arthritis.
News
A recent study demonstrated the safety and long-term effectiveness of bimekizumab, with participants maintaining high PASI scores through 60 weeks of treatment.
News
Findings from a recent study showed that satisfaction with physicians is associated with mental health comorbidities among patients with psoriasis.
News
Using data from a large registry, researchers investigated the real-world safety of several systemic medications including etanercept, secukinumab, ustekinumab, and apremilast.
NPF Endorsed Features
Patients with psoriasis and psoriatic arthritis have increased calls to their dermatologist for advice on continuance of their therapy during uncertain times. Guidance from national organizations provide answers that dermatologists can pass on to
Back to Top